Very interesting....News item.. Options for oct expire in two days.. We need some positive news from the company itself in regards to the Kiacta drug.... Or the hyp will just drive the stock back down.. I'm thinking Nov we will hear something good from the company. Oct to Dec period has paid off well for Neurochem shareholders in the past years... Betting with the odds..BTK Biotech index is also racing upwards.... so Money flow is coming into our sector.. Go NRMX